In vitro studies on the mechanisms of CX3CL1-induced migration revealed that CX3CL1 induces increased IFN-γ and TNF-α gene expressions and increased IFN-γ secretion in CD4+ T lymphocytes derived from RRMS patients but not in control patients. The gene discussed is CX3CL1; the disease is relapsing-remitting multiple sclerosis.